Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multinational, Multicentre, Randomized, Open, Parallel Group Study on the Efficacy and Safety of Bemiparin Sodium (LMWH) Compared to Enoxaparin Sodium (LMWH) in the Treatment of Acute Deep Vein Thrombosis (DVT)

Next Previous
Trial Profile

A Multinational, Multicentre, Randomized, Open, Parallel Group Study on the Efficacy and Safety of Bemiparin Sodium (LMWH) Compared to Enoxaparin Sodium (LMWH) in the Treatment of Acute Deep Vein Thrombosis (DVT)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 19 Dec 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bemiparin sodium (Primary) ; Enoxaparin sodium; Warfarin
  • Indications Deep vein thrombosis; Thrombosis; Venous thromboembolism
  • Focus Registrational; Therapeutic Use
  • Sponsors Berlin Chemie

Most Recent Events

  • 06 Dec 2017 Primary endpoint of percentage of patients with an improvement in thrombotic burden at visit 3 has been met, according to results published in the Clinical Drug Investigation.
  • 06 Dec 2017 Results published in the Clinical Drug Investigation
  • 03 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top